Valeant Pharmaceuticals International (VRX) · page 40 of 47
The slide justifies using non-healthcare benchmarks for valuation by highlighting similar margin and growth profiles.
Conference presentation · comparison_table · compare_peers · dense density
Slide locked Sign in to view
Slide schematic 4/4
callout 1/1 source-note 1/1 table 1/1 title 1/1
Components 4
primary source-note data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1